Product Information
ESCITALOPRAM 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0421 per EA under NDC 16571075510. Its NADAC has been published 142 times since Oct 11, 2023.
Strength
5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571075510
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA078777On Market Since
6/10/2023
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 5 MG TABLET has been published 142 times since Oct 11, 2023, and over the history we have for it it has declined 6.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0421 per EA |
|---|---|
| All-time high | $0.0501 (Apr 10, 2024) |
| All-time low | $0.0328 (Nov 20, 2024) |
| 52-week high | $0.0474 |
| 52-week low | $0.0412 |
| Median price | $0.0439 |
| Average price | $0.0435 |
| Largest weekly change | -27.3% (Nov 20, 2024) |
| Weeks tracked | 142 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0421 per EA (NDC 16571075510), effective Jun 24, 2026.
How has the price of ESCITALOPRAM 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 5 MG TABLET has declined 6.1%. It has been tracked across 142 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 5 MG TABLET?
Since Oct 11, 2023, the NADAC for ESCITALOPRAM 5 MG TABLET has ranged from a low of $0.0328 (Nov 20, 2024) to a high of $0.0501 (Apr 10, 2024), with a median of $0.0439 per EA.
Are there cheaper alternatives to ESCITALOPRAM 5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ESCITALOPRAM 5 MG TABLET, but none are currently priced below it.
Who manufactures ESCITALOPRAM 5 MG TABLET?
ESCITALOPRAM 5 MG TABLET (NDC 16571075510) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification